Sophisticated and simple
Overview: Promising Phase 2 Results in The Lancet Apnimed has announced that positive Phase 2 results from the FLOW study evaluating sulthiame, an oral carbonic…

Key takeaway: PSA screening improves outcomes Prostate cancer remains a major health concern worldwide, but new results from the 23-year European Randomized Study of Screening…

Introduction: A Forty-Year Arc of Impact HIV/AIDS research has not only transformed care for people living with HIV but has become a powerful engine of…

Turning Data Into Better Cancer Care In Calgary, Alberta, a physician-scientist is reshaping how cancer care is delivered by translating data into real-world improvements for…

Major Gift Fuels Long-Term Cancer Research at Western University Canada faces a sobering reality: almost half of the population is expected to receive a cancer…

Kathryn North AC Named AMRAB Chair to Guide Australia’s Medical Research Future Fund Professor Kathryn North AC, the Director of Murdoch Children’s Research Institute (MCRI)…

Groundbreaking Gene Therapy Brings New Hope for ADA-SCID Patients A nine-year-old boy from Portlaoise, Ireland, has become one of the most compelling success stories in…

Overview: A new immunotherapy approach in HIV Researchers report promising safety data from the first-in-human trial of an anti-PD-1 antibody, budigalimab, in people living with…

Groundbreaking step toward protecting the brain during radiation therapy Radiation therapy remains a cornerstone in treating brain cancers, but its cognitive side effects can shadow…

New research offers a targeted safeguard for brain cancer patients undergoing radiation therapy For many cancer survivors, the battle isn’t over once tumors are treated.…
